Kingfa and Beijing University Partner on Green Biomanufacturing

by Sven Cammerer
Kingfa Green Biomanufacturing Bio-Based R&D China Partnership
Kingfa and Beijing University Partner on Green Biomanufacturing

Strategic Cooperation in Green Biomanufacturing

Kingfa Sci. & Tech. Co., Ltd. and Beijing University of Chemical Technology have signed a strategic cooperation agreement targeting breakthroughs in green biomanufacturing — the use of biochemical technologies and biocatalysis to produce materials from renewable feedstocks, replacing traditional petrochemical routes.

The partnership aligns with China’s national goals of carbon peaking by 2030 and carbon neutrality by 2060, where biomanufacturing is identified as a key enabling technology for the transition away from fossil-based materials.

Research Focus Areas

The cooperation will focus on several critical areas at the intersection of biotechnology and materials science:

Bio-Based Monomer Production

Developing biological pathways to produce key monomers currently derived from petroleum — enabling bio-based versions of materials like PBS, PBAT, and novel polyesters without changing their end-use performance.

Biocatalysis and Fermentation

Using engineered enzymes and microbial fermentation to convert renewable feedstocks (sugars, lignocellulosic biomass, waste oils) into chemical building blocks for polymer synthesis.

Novel Bio-Based Polymers

Exploring entirely new bio-based polymer architectures that combine biodegradability with enhanced mechanical, thermal, and barrier properties — pushing beyond the performance limitations of first-generation bioplastics.

Process Intensification

Improving the economics of bio-based production through continuous fermentation, catalytic process optimisation, and integrated biorefinery concepts that reduce costs toward parity with petrochemical alternatives.

Why This Matters

Current bio-based plastics face two fundamental challenges:

  1. Cost premium — Bio-based routes typically cost 20–100% more than petrochemical equivalents, limiting market adoption to premium applications and regulatory-driven demand
  2. Scale limitations — Most bio-based monomer production remains at pilot or demo scale, insufficient for the multi-million-tonne volumes of the commodity plastics market

The Kingfa–BUCT partnership addresses both challenges simultaneously: process intensification to reduce costs, and Kingfa’s manufacturing scale to move from lab to commercial volumes. Kingfa’s Zhuhai Biomaterial Base (53.3 hectares) provides a unique platform for scaling up promising lab results into industrial production.

Broader Industry Context

This partnership reflects a growing trend of industry–academia collaboration in green chemistry. Similar initiatives include:

  • Covestro’s Bio4PURConti project for continuous bio-based aniline production with EU Horizon funding
  • BASF’s partnership with various universities on bio-based acrylic acid and BDO
  • DuPont/IFF’s bio-based PDO production at commercial scale

Kingfa’s advantage lies in its position as China’s largest plastics compounder, with direct access to domestic feedstocks, established compounding infrastructure, and strong relationships with packaging and automotive OEMs that create immediate demand pull for bio-based alternatives.

About Kingfa

Kingfa Sci. & Tech. Co., Ltd. (SSE: 600143) is Asia’s largest modified plastics company with 64 subsidiaries worldwide and H1 2025 revenue of RMB 31.6 billion. Its ECOPOND brand biodegradable compounds serve the compostable packaging, agricultural film, and food service markets.

Source: Kingfa Sci. & Tech.